Curium Announces Submission of an Investigational New Drug (IND) Application for Cu-64 PSMA I&T
August 24, 2021 02:15 ET | Curium
ST. LOUIS, MO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Curium announced today that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for Cu-64...
Curium Acquires Austrian Radiopharmaceuticals Company IASON
May 31, 2021 22:00 ET | Curium
Paris, May 31, 2021 (GLOBE NEWSWIRE) -- (Graz and Paris – June 1st, 2021) —Curium has successfully completed the acquisition of the Austrian radiopharmaceuticals Company IASON, further expanding its...
RadioMedix & Curium Announce Detectnetᵀᴹ (copper Cu 64 dotatate injection) Inclusion on NCCN Guidelines®
May 05, 2021 10:50 ET | Curium
St. Louis, MO, May 05, 2021 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that Detectnet is now included in the National Comprehensive Cancer Network® (NCCN)...
RadioMedix & Curium Announce Detectnetᵀᴹ (copper Cu 64 dotatate injection) Inclusion on NCCN Guidelines®
May 05, 2021 02:30 ET | Curium
St. Louis, MO, May 05, 2021 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that Detectnet is now included in the National Comprehensive Cancer Network® (NCCN)...
Curium Announces Filing of a Generic Version of DaTscanᵀᴹ (Ioflupane I 123 Injection) in the U.S.
May 04, 2021 02:30 ET | Curium
St. Louis, MO, May 04, 2021 (GLOBE NEWSWIRE) -- Curium announced today that it submitted an abbreviated new drug application for a generic version of DaTscan (Ioflupane I 123 Injection) with the...
Curium to Expand Noblesville Facility’s Workforce
April 28, 2021 02:30 ET | Curium
St. Louis, MO, April 28, 2021 (GLOBE NEWSWIRE) -- Curium, the world’s largest nuclear medicine company, has announced plans to invest in new jobs at its Noblesville location – furthering its...
RadioMedix & Curium Announce Simplified Coding for DetectnetTM (copper Cu 64 dotatate injection)
March 23, 2021 02:15 ET | Curium
St. Louis, MO, March 23, 2021 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that the Centers for Medicare & Medicaid Services (CMS) has simplified the...
Eckert & Ziegler’s GalliaPharm® distributed by Curium in France
March 01, 2021 19:15 ET | Curium
Berlin, Germany and Paris, France, March 01, 2021 (GLOBE NEWSWIRE) -- Eckert & Ziegler Radiopharma GmbH and Curium PET France have decided to reinforce their existing long term partnership by...
RadioMedix & Curium Announce Permanent HCPCS Code for DetectnetTM (copper Cu 64 dotatate injection)
January 26, 2021 02:30 ET | Curium
St. Louis, MO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that the Centers for Medicare & Medicaid Services (CMS) has granted Detectnet a...
Radiomedix Curium CoBrand Logo .jpg
RadioMedix & Curium Announce CMS Transitional Pass-Through Status for Detectnet™ (copper Cu 64 dotatate injection)
December 09, 2020 01:10 ET | Curium
ST. LOUIS, Dec. 09, 2020 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that the Centers for Medicare & Medicaid Services (CMS) has granted Detectnet...